The results of the ALASCCA RCT, showing lower recurrence rate after adjuvant aspirin in patients with local CRC and PIK3CA mutations in exon 9 or 20, are published. As the PI in Finland I’d like to thank all collaborators at Meilahti and Jorvi Hospitals

www.nejm.org/doi/full/10....

Our PROSPERITY trial, comparing protective ileostomy and colostomy in anterior resection, will start soon. See the protocol in BMJ open bmjopen.bmj.com/content/bmjo...

For #ColorectalCancerAwarenessMonth, surgeon experts share insights into why the disease is affecting more younger adults, including patients in their 20s and 30s, and what can be done to prevent it.

🔗 Read their top 4️⃣ things to know: buff.ly/Zw6017o

March is Colorectal Cancer Awareness Month. Please go here for patient materials buff.ly/3EWWe7D

Prof Anna Martling presented results of #ALASCCA trial at #ASCOGI25, showing low dose aspirin reduce the recurrence rate by 50% in CRC-patients with tumors having mutations in the PI3K pathway. Proud of taking part in this trial with my team at Helsinki University Hospital, Colorectal Unit

Tumour deposit count is an independent prognostic factor in colorectal cancer—a population-based cohort study
➡️ doi.org/10.1093/bjs/...

Screen-detected colon cancer leads to better outcomes.

by Lucocq J, Trinder T (...) Muthukumarasamy G et 4 al. in World J Surg #Surgery #SurgSky #generalsurgery #MedSky

🪡 read our summary here
📖 read the article: https://onlinelibrary.wiley.com/doi/10.1002/wjs.12409